{"id":"NCT01193257","sponsor":"Millennium Pharmaceuticals, Inc.","briefTitle":"Study Comparing Orteronel Plus Prednisone in Participants With Metastatic Castration-Resistant Prostate Cancer.","officialTitle":"A Phase 3, Randomized, Double-Blind, Multicenter Trial Comparing Orteronel (TAK-700) Plus Prednisone With Placebo Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer That Has Progressed During or Following Docetaxel-based Therapy.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-11-15","primaryCompletion":"2013-05-16","completion":"2016-02-29","firstPosted":"2010-09-01","resultsPosted":"2018-12-19","lastUpdate":"2018-12-19"},"enrollment":1099,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Prostate Cancer"],"interventions":[{"type":"DRUG","name":"Orteronel","otherNames":["TAK-700"]},{"type":"DRUG","name":"Prednisone","otherNames":[]},{"type":"DRUG","name":"Orteronel Placebo","otherNames":[]}],"arms":[{"label":"Orteronel + prednisone","type":"EXPERIMENTAL"},{"label":"Placebo + prednisone","type":"PLACEBO_COMPARATOR"}],"summary":"This is a randomized, double-blind, multicenter, phase 3 study evaluating orteronel plus prednisone compared with placebo plus prednisone in men with metastatic, castration-resistant prostate cancer (mCRPC) that has progressed following Docetaxel-based therapy","primaryOutcome":{"measure":"Overall Survival","timeFrame":"Baseline until death (approximately up to 4.5 years)","effectByArm":[{"arm":"Placebo + Prednisone","deltaMin":15.3,"sd":null},{"arm":"Orteronel + Prednisone","deltaMin":17.1,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.12085"}]},"eligibility":{"minAge":"18 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":78,"countries":["United States","Australia","Belgium","Canada","Czechia","Estonia","Finland","France","Greece","Hungary","Italy","Netherlands","Poland","Spain"]},"refs":{"pmids":["29272162","26031410","25624429"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":148,"n":363},"commonTop":["Nausea","Vomiting","Fatigue","Constipation","Decreased appetite"]}}